Allegro’s injectable osteoarthritis treatment generates positive safety results in preclinical studies
Microparticle hydrogel shows clean systemic toxicity profile over 4 weeks and 13 weeks Treatment designed to restore shock-absorbing capacities of joints in osteoarthritis Allegro plans to start pivotal clinical trials in osteoarthritis patients in 2025 Liege, Belgium – 25 March 2025 (08:30 CET) – Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for degenerative […]